Indication*

Cryptococcal meningitis; coccidioidomycosis; invasive candidiasis. Mucosal candidiasis including oroppharyngeal. oesophageal candidiasis, candiduria & chronic mucocutaneous candidiasis. chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient. Prophylaxis of relapsed cryptococcal meningitis in patients with high risk of occurrence; relapsed oropharyngeal or oesophageal candidiasis in HIV patients who are at high risk of occurrence; relapsed oropharyngeal or oesophageal candidiasis in HIV patients who are at high risk of experiencing relapse; candidal infections in patients with prolonged neutropenia (eg,haematological malignancies receiving chemotherapy or receiving hematopoietic stem cell transplantation). Newborn infants, infants, toddlers, children & adolescent 0-17 year: Treatment of mucosal/invasive candiadiasis, cryptococca meningitis & prophylaxis of candidal infections in immunocompromised patients; maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.

Directions for Use*

Administration*

*written indications, directions, and administration are updated as of January 28, 2024 and may not be accurate with the actual product purchased. Please read the details in the packaging.

Share

Share

Link

Close share Copy link

View full details